Literature DB >> 7927774

Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.

M K Aydintug1, Y Gu, M T Philipp.   

Abstract

We identified surface antigens of Borrelia burgdorferi that are targeted by antibody-dependent, complement-mediated killing (ADCK) in the rhesus monkey. For this purpose, we had available serum samples from three animals infected with B. burgdorferi JD1 by needle inoculation and from two monkeys that were infected with the same B. burgdorferi strain by Ixodes scapularis tick bite. Sera from monkeys from the first group contained antibodies to OspA and OspB detectable by Western blot (immunoblot) using whole B. burgdorferi antigens, whereas serum samples from animals in the second group did not. The targeting of OspA and OspB by functional antibodies was demonstrated directly by showing that ADCK was partially inhibited when antibodies were preincubated with an excess of soluble recombinant OspA or OspB. Simultaneous addition of OspA and OspB did not result in an additive inhibitory effect on ADCK, a result that suggests that the epitopes on OspA and that on OspB targeted by antibody in this mechanism are the same, or at least cross-reacting. The targeting of non-OspA, non-OspB surface antigens was inferred from the fact that sera from tick-inoculated animals, which did not contain detectable anti-OspA or anti-OspB antibodies, were able to effect ADCK. This killing effect was not inhibitable by the addition of recombinant OspA or OspB or both proteins together. We also showed that both immunoglobulin G and M antibodies participate in the ADCK mechanism in the rhesus monkey. Rhesus complement does not kill B. burgdorferi in vitro in the absence of antibody, and antibody alone is effective in killing only at serum dilutions lower than 1:15. However, such "complement-independent" antibodies were not present in all bleeds. Two main conclusions may be drawn from the analysis of our results. First, both OspA and OspB are targeted by the ADCK mechanism in the rhesus monkey. Second, one or more B. burgdorferi surface antigens that are neither OspA nor OspB also participate in ADCK.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927774      PMCID: PMC303209          DOI: 10.1128/iai.62.11.4929-4937.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.

Authors:  C A Hughes; S M Engstrom; L A Coleman; C B Kodner; R C Johnson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

2.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

3.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.

Authors:  L K Bockenstedt; E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

5.  Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice.

Authors:  L Gern; U E Schaible; M M Simon
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

6.  Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi.

Authors:  W M Whitmire; C F Garon
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.

Authors:  U E Schaible; L Gern; R Wallich; M D Kramer; M Prester; M M Simon
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

9.  Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.

Authors:  M T Philipp; M K Aydintug; R P Bohm; F B Cogswell; V A Dennis; H N Lanners; R C Lowrie; E D Roberts; M D Conway; M Karaçorlu; G A Peyman; D J Gubler; B J Johnson; J Piesman; Y Gu
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.

Authors:  S K Kochi; R C Johnson; A P Dalmasso
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  28 in total

1.  Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.

Authors:  B K Du Chateau; D M England; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.

Authors:  E L Munson; B K Du Chateau; D A Jobe; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement.

Authors:  J M Nowling; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  W T Golde; J Piesman; M C Dolan; M Kramer; P Hauser; Y Lobet; C Capiau; P Desmons; P Voet; D Dearwester; J C Frantz
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Authors:  S M Callister; D A Jobe; R F Schell; C S Pavia; S D Lovrich
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

7.  Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.

Authors:  J R Creson; L C Lim; N J Glowacki; S M Callister; R F Schell
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

8.  Outer Membrane Proteins BB0405 and BB0406 Are Immunogenic, but Only BB0405 Is Required for Borrelia burgdorferi Infection.

Authors:  Binu Shrestha; Melisha R Kenedy; Darrin R Akins
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

9.  Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity.

Authors:  D M Foley; Y P Wang; X Y Wu; D R Blanco; M A Lovett; J N Miller
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

10.  Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.

Authors:  Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.